2025
Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy
Chiang A, Garcia M, Carlisle J, Dowlati A, Reguart N, Felip E, Jost P, Steeghs N, Stec R, Gadgeel S, Loong H, Jiang W, Hamidi A, Parkes A, Paz-Ares L. Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy. ESMO Open 2025, 10: 104538. PMID: 40187110, PMCID: PMC12002761, DOI: 10.1016/j.esmoop.2025.104538.Peer-Reviewed Original ResearchConceptsSmall-cell lung cancerCytokine release syndromeInpatient monitoringRate of treatment-related adverse eventsRisk of cytokine release syndromeTreated small-cell lung cancerT cell-engaging immunotherapiesTreatment-related adverse eventsDelta-like ligand 3First-in-human studyPrimary endpointSurvival outcomesMedian timeAdverse eventsLung cancerEmergency room visitsClinical trialsQ2WOutpatient monitoringSafety outcomesInpatient groupHospitalization ratesCycle 1Room visitsPatients826 Analysis of National Burn Repository: Impact of Dermal Templates in Burn Management 2008 to 2021
Crombie R, Witherel C. 826 Analysis of National Burn Repository: Impact of Dermal Templates in Burn Management 2008 to 2021. Journal Of Burn Care & Research 2025, 46: s275-s275. PMCID: PMC11958102, DOI: 10.1093/jbcr/iraf019.357.Peer-Reviewed Original ResearchDermal templateNational Burn RepositoryAssociated with fewer infectionsHealth economic implicationsBurn RepositoryPatient demographic informationThird-degree burnsThermal burn injuryDermal regeneration templateEmergency room visitsNormal patientsBurn patientsFewer infectionsPatientsImprove outcomesClinical performanceRegistry dataOutcome measuresBurn injuryCost of careCare algorithmTBSARoom visitsRegeneration templateBurn managementResiliency in Child–Caregiver Dyads and the Impact on Health Outcomes in Sickle Cell Disease
Zavadil J, Azul M, Carpenter B, Calhoun C. Resiliency in Child–Caregiver Dyads and the Impact on Health Outcomes in Sickle Cell Disease. Children 2025, 12: 394. PMID: 40310076, PMCID: PMC12025687, DOI: 10.3390/children12040394.Peer-Reviewed Original ResearchMedian resilience scoreConnor-Davidson Resilience ScaleCaregiver resilienceChild-caregiver dyadsHistory of strokeResilience scoresHealth outcomesChildren's resiliencePerceived stressStress scoresChild's SCDCaregivers' perceived stressSickle cell diseasePerceived stress scoresCross-sectional cohort studyPerceived Stress ScaleAssociated with fewer hospitalizationsDavidson Resilience ScaleChronic health diseasesEmergency room visitsAssociated with childrenCOVID-19 pandemicFrequency of stressorsPSS-10Child caregivers
2024
Impact of Fatigue on Work Productivity, Activity Impairment, and Healthcare Resource Utilization in Inflammatory Bowel Disease
Feagins L, Moore P, Crabtree M, Eliot M, Lemay C, Loughlin A, Gaidos J. Impact of Fatigue on Work Productivity, Activity Impairment, and Healthcare Resource Utilization in Inflammatory Bowel Disease. Crohn's & Colitis 360 2024, 7: otae073. PMID: 39742035, PMCID: PMC11684069, DOI: 10.1093/crocol/otae073.Peer-Reviewed Original ResearchRates of healthcare utilizationImpact of fatigueHealthcare utilizationHigher fatigueLower fatigueActivity impairmentRate of fatigueWork productivity lossEmergency room visitsHealthcare resource utilizationIBD registryLogistic regression analysisFatigue scoresDisease-related hospitalizationsRoom visitsCrohn's diseaseUlcerative colitisWPAIInactive diseaseWork productivitySubgroup analysisSubgroup analysis of patientsAbsenteeismHealthcarePresenteeismImplementation of American Society of Hematology (ASH) Neuro-Related Guidelines at a Sickle Cell Center: How Are We Doing?
Afranie-Sakyi J, Karimi M, Bozzo J, Cole J, Van Doren L, Calhoun C. Implementation of American Society of Hematology (ASH) Neuro-Related Guidelines at a Sickle Cell Center: How Are We Doing? Blood 2024, 144: 5009-5009. DOI: 10.1182/blood-2024-201816.Peer-Reviewed Original ResearchYale New Haven Health SystemHistory of strokeCognitive screeningGuideline publicationHealth systemSilent cerebral infarctionCognitive disordersImplementation ratePredictors of screeningSickle cell diseaseRates of screeningMood disordersAmerican Society of HematologyPrevalence of cognitive disordersDetect silent cerebral infarctsDevelopment of interventionsCognitive impairmentManual chart reviewICD-10 diagnosisEmergency room visitsDiagnosis of sickle cell diseaseSickle Cell CenterAmerican Society of Hematology guidelinesOutpatient encountersMRI screeningScreening for Cognitive Impairment and Depression in Sickle Cell Disease: How Are We Doing?
Afranie-Sakyi J, Karimi M, Bozzo J, Cole J, Van Doren L, Calhoun C. Screening for Cognitive Impairment and Depression in Sickle Cell Disease: How Are We Doing? Blood 2024, 144: 2249-2249. DOI: 10.1182/blood-2024-211906.Peer-Reviewed Original ResearchPatient Health QuestionnaireCognitive screeningAmerican Society of HematologyPsychiatric disordersSickle cell diseaseMood screeningMood disordersCognitive disordersDisorder screeningYale New Haven Health SystemPredictors of screeningDisease-modifying therapiesICD-10 diagnosisManual chart reviewImplementation of recommendationsEmergency room visitsDiagnosis of sickle cell diseaseHistory of strokeCell diseaseScreening ratesAnxious symptomsHealthcare teamPromote screeningNeuropsychological testsCognitive domainsNational Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer
Kim L, Moore M, Schneider E, Canner J, Ayyala H, Chen J, Anant P, Graetz E, Lynch M, Zanieski G, Gillego A, Valero M, Proussaloglou E, Berger E, Golshan M, Greenup R, Park T. National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer. Annals Of Surgical Oncology 2024, 31: 9088-9099. PMID: 39322830, DOI: 10.1245/s10434-024-16107-w.Peer-Reviewed Original ResearchHR patientsLymph nodesRate of neoadjuvant chemotherapyHospital admissionNational patterns of careEmergency departmentDecrease wound complicationsNeoadjuvant chemo-Hospital re-admissionNeoadjuvant chemotherapyIn-hospital admissionRate of reconstructionPerioperative outcomesPostoperative hematomaComplication ratePostoperative complicationsWound complicationsHome recoveryPatterns of careBreast cancerMastectomyEmergency room visitsMultivariate analysisComplicationsPatientsMDS-772 Time Toxicity for Patients Receiving Oral Versus Parenteral Hypomethylating Agents for Myelodysplastic Syndromes/Neoplasms
Zeidan A, Olopoenia A, Costantino H, Modi K, Salimi T, Washington T, Krenitsky J, Epstein R. MDS-772 Time Toxicity for Patients Receiving Oral Versus Parenteral Hypomethylating Agents for Myelodysplastic Syndromes/Neoplasms. Clinical Lymphoma Myeloma & Leukemia 2024, 24: s406. DOI: 10.1016/s2152-2650(24)01382-x.Peer-Reviewed Original ResearchHMA therapyRetrospective analysis of adult patientsAnalysis of adult patientsRoute of administrationMedian life expectancyPropensity score matchingHypomethylating agentsMDS treatmentBurden of treatmentAdult patientsPatient cohortInfusion dayParenteral treatmentMatched CohortResults PatientsRetrospective analysisOlder patientsEmergency room visitsCancer therapyHMA treatmentParenteral administrationTherapyPatientsOutpatient settingScore matchingIxekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study
Danve A, Vadhariya A, Lisse J, Cholayil A, Bansal N, Bello N, Bakewell C. Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study. Rheumatology And Therapy 2024, 11: 1333-1345. PMID: 39162898, PMCID: PMC11422398, DOI: 10.1007/s40744-024-00710-0.Peer-Reviewed Original ResearchHealth care resource utilizationFollow-up periodTumor necrosis factor-alpha inhibitorsTreatment patternsAxial spondyloarthritisPre-indexMethodsThis retrospective cohort studyBiologic-experienced patientsCharlson Comorbidity Index scoreRetrospective cohort studyClaims database studyIntroductionReal-world dataAssessed patient demographicsComorbidity Index scoreHigher comorbidity burdenProportion of daysBiologic-experiencedPatient demographicsClinical characteristicsIxekizumabIndex dateCohort studyPharmacy enrollmentEmergency room visitsAxSpAEffects of air pollution on emergency room visits for mental disorders: risks and effect modification by comorbid physical disorders and personal characteristics
Yoo E, Roberts J, Chen K. Effects of air pollution on emergency room visits for mental disorders: risks and effect modification by comorbid physical disorders and personal characteristics. Environmental Research Health 2024, 2: 025001. DOI: 10.1088/2752-5309/ad1f3f.Peer-Reviewed Original ResearchComorbid physical disordersMental disordersPhysical disordersPersonal characteristicsEffect modificationER visitsNegatively impact mental healthAssociated with ER visitsPotential effect modificationCase-crossover designPotential moderatorsEffects of air pollutionEmergency room visitsEmergency roomMental healthRespiratory diseaseDisordersLevels of air pollutionStratified analysisRoom visitsEffects of daily changesAir pollutionDemographic characteristicsVisitsPrimary diagnosis
2023
Self‐reported COVID‐19 infection, and illness severity associated with a large professional‐society meeting of the AAPM in 2022
Talcott W, Ford E, Johnson J, Lincoln H, Evans S. Self‐reported COVID‐19 infection, and illness severity associated with a large professional‐society meeting of the AAPM in 2022. Medical Physics 2023, 50: 4689-4694. PMID: 37415569, DOI: 10.1002/mp.16592.Peer-Reviewed Original ResearchConceptsAmerican Association of Physicists in MedicineCOVID-19 infectionIn-person attendeesOdds ratioSeverity of COVID-19 infectionConfidence intervalsMultivariate logistic regressionAssociated with COVID-19 infectionInfection rateSeverity of infectionNational medical conferenceEmergency room visitsMultivariate analysisSelf-limitingCOVID-19 treatmentResponse rateIllness severityInfectionHospital admissionIn-person meetingsLogistic regressionRoom visitsIn-personSeverityCOVID-19Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States
Naidu S, Sutton M, Gao W, Fine J, Xie J, Desai N, Owens A. Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States. Journal Of Medical Economics 2023, 26: 682-690. PMID: 37170479, DOI: 10.1080/13696998.2023.2208966.Peer-Reviewed Original ResearchConceptsObstructive hypertrophic cardiomyopathyDefinitive diagnosisHypertrophic cardiomyopathyHCM diagnosisMedicare Supplemental databasesIBM MarketScan CommercialEmergency room visitsAdministrative claims dataMisclassification of patientsEligible patientsMarketScan CommercialMost patientsRoom visitsAlternative diagnosesPotential misdiagnosesCardiovascular conditionsInappropriate treatmentDatabase studyClaims dataHealthcare costsDiagnostic journeyPatientsEconomic burdenCurrent studyDiagnostic historyAssociations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort
Power S, Bickel K, Chen R, Chiang A, Garrett-Mayer L, Makhoul I, Mougalian S, Shapiro C, Siegel R, Smith C, Rocque G, Kozlik M, Crist S, Kamal A. Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort. JCO Oncology Practice 2023, 19: e520-e526. PMID: 36669136, DOI: 10.1200/op.22.00464.Peer-Reviewed Original ResearchConceptsDays of lifeEmergency room visitsAD completionChemotherapy receiptRoom visitsAdvance directivesIntensive care unit admissionLife quality measuresCare unit admissionEOL quality measuresOutcomes of patientsIntensive care unitPatient-level dataChi-square testHigh rateUnit admissionHospice enrollmentCare unitOncology visitsPatient cohortPatient enrollmentPatientsCancer diagnosisVisitsQuality measures
2022
Short-term exposure to air pollution and mental disorders: a case-crossover study in New York City
Yoo E, Roberts J, Eum Y, Li X, Chu L, Wang P, Chen K. Short-term exposure to air pollution and mental disorders: a case-crossover study in New York City. Environmental Research Health 2022, 1: 015001. DOI: 10.1088/2752-5309/ac6439.Peer-Reviewed Original ResearchER visitsAir pollution exposureMental disordersShort-term exposureRace/ethnicityPollution exposureAmbient air pollution exposureEmergency room visitsConditional logistic regressionCase-crossover studySingle-day lagsCase-crossover designAge group 19Ambient air pollutionRoom visitsRelative riskPsychotic disordersLogistic regressionNew York CityDaily air pollution exposureSpecific disordersVisitsDisordersPpb increaseGroup 19Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic
Meshberg‐Cohen S, Farook M, Gross G, Levina V, DeViva J. Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic. American Journal On Addictions 2022, 32: 32-39. PMID: 36286598, DOI: 10.1111/ajad.13347.Peer-Reviewed Original ResearchConceptsAlcohol use disorderTreatment modalitiesUse disordersClinical variablesCOVID-19Outpatient substance use disorder treatmentElectronic medical record dataSubstance use disorder treatmentTreatment utilization patternsMain treatment modalityRetrospective electronic medical record dataEmergency room visitsOpioid use disorderPsychiatric emergency room visitsMedical record dataUse disorder treatmentUtilization patternsCocaine use disorderBinary logistic regressionRoom visitsSUD diagnosisTelephone appointmentsTreatment utilizationChi-square analysisNumber of visitsPrevalence and Predictors of Seizure Clusters in Pediatric Patients With Epilepsy: The Harvard-Yale Pediatric Seizure Cluster Study
Jafarpour S, Fong MWK, Detyniecki K, Khan A, Jackson-Shaheed E, Wang X, Lewis S, Benjamin R, Gaínza-Lein M, O'Bryan J, Hirsch LJ, Loddenkemper T. Prevalence and Predictors of Seizure Clusters in Pediatric Patients With Epilepsy: The Harvard-Yale Pediatric Seizure Cluster Study. Pediatric Neurology 2022, 137: 22-29. PMID: 36208614, DOI: 10.1016/j.pediatrneurol.2022.08.014.Peer-Reviewed Original ResearchConceptsSeizure clustersRescue medicationPediatric patientsSeizure frequencyIntermediate-risk groupEmergency department visitsHigh seizure frequencyTwo-center studyEmergency room visitsHigh-risk groupActive seizuresMore seizuresDepartment visitsStatus epilepticusRoom visitsAdverse outcomesEpilepsy severityIsolated seizureSeizure diariesRisk factorsRisk groupsGreater oddsPatientsMedicationsSeizuresFeasibility of the Transport PLUS intervention to improve the transitions of care for patients transported home by ambulance: a non-randomized pilot study
Munjal KG, Yeturu SK, Chapin HH, Tan N, Gregoriou D, Garcia D, Grudzen C, Hwang U, Morano B, Neher H, Gorbenko K, Youngblood G, Misra A, Dietrich S, Gonzalez C, Appel G, Jacobs E, Siu A, Richardson LD. Feasibility of the Transport PLUS intervention to improve the transitions of care for patients transported home by ambulance: a non-randomized pilot study. Pilot And Feasibility Studies 2022, 8: 169. PMID: 35932067, PMCID: PMC9354351, DOI: 10.1186/s40814-022-01138-5.Peer-Reviewed Original ResearchCommunity health workersEmergency medical techniciansPatient acceptanceNon-randomized pilot studyRate of readmissionMajority of patientsPopulation of patientsEmergency room visitsTransitions of careRandomized control trialElectronic health recordsEligible patientsED revisitsFeasibility outcomesClinical outcomesRoom visitsDischarge instructionsGeriatric populationHealth workersHigh riskControl trialHome visitsPatientsPatient encountersCommunity paramedicineComparison of mental health outcomes of augmenting medications for patients with posttraumatic stress disorder: A national veterans affairs study
Ranney R, Maguen S, Woods A, Seal K, Neylan T, Bernardy N, Wiechers I, Ryder A, Cohen B. Comparison of mental health outcomes of augmenting medications for patients with posttraumatic stress disorder: A national veterans affairs study. Journal Of Evaluation In Clinical Practice 2022, 29: 191-202. PMID: 35709244, DOI: 10.1111/jep.13726.Peer-Reviewed Original ResearchConceptsEmergency room visitsPosttraumatic stress disorderPsychiatric emergency room visitsAugmenting medicationsRoom visitsMental health outcomesPsychiatric hospitalizationHospitalization/emergency room visitsHealth outcomesStress disorderPTSD symptomsVeterans Affairs studyDiagnosis of PTSDMedication groupClinical trialsAdditional interventionsMedicationsBaseline levelsPatientsVeterans AffairsNew prescriptionsElectronic recordsVisitsHospitalizationSymptomsDecreased Resiliency Associated with Increased Hospitalizations for Children with Sickle Cell Disease (S535)
Zavadil J, Carpenter B, Calhoun C. Decreased Resiliency Associated with Increased Hospitalizations for Children with Sickle Cell Disease (S535). Journal Of Pain And Symptom Management 2022, 63: 924-925. DOI: 10.1016/j.jpainsymman.2022.02.158.Peer-Reviewed Original ResearchSickle cell disease managementCD-RISCParental resilienceFrequency of hospitalizationSources of stressPSS-10Resilience of childrenConnor-Davidson Resilience ScaleSickle cell diseasePSS-10 scoreChildren's resiliencePerceived Stress ScaleCD-RISC scoreEmergency room visitsHistory of strokeDepression ScalePsychosocial factorsChild healthChronic illnessPerceived stressStress ScaleResilience scoresCOVID pandemicResilience ScaleImprove resilienceImpact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes
Zeidan AM, Joshi N, Kale H, Wang WJ, Corman S, Salimi T, Epstein RS. Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes. Clinical Lymphoma Myeloma & Leukemia 2022, 22: 670-679. PMID: 35614009, DOI: 10.1016/j.clml.2022.04.016.Peer-Reviewed Original ResearchConceptsHigh-risk myelodysplastic syndromeHMA therapyPoor performance statusRate of hospitalizationSEER-Medicare databaseMyelodysplastic syndromeER visitsEarly discontinuationPerformance statusEmergency roomOlder agePredictors of discontinuationEmergency room visitsHigh-risk groupHigh economic burdenTreatment discontinuationExcess blastsMore hospitalizationsNew hospitalizationRefractory anemiaRoom visitsHigh riskDiscontinuationMD diagnosisAgent use
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply